Personal information

Verified email addresses

Verified email domains

Activities

Employment (3)

Düsseldorf University Hospital: Düsseldorf, DE

2022-11-01 to present | Resident Physician (Department of Hematology, Oncology and Clinical Immunology)
Employment
Source: Self-asserted source
Peter-Martin Bruch

University Hospital Heidelberg: Heidelberg, DE

2020-10-01 to 2022-10-31 | Resident Physician (Department of Hematology, Oncology and Rheumatology)
Employment
Source: Self-asserted source
Peter-Martin Bruch

University Hospital Heidelberg: Heidelberg, DE

2017-03 to 2020-09-30 | MD student (Department of Hematology, Oncology and Rheumatology)
Employment
Source: Self-asserted source
Peter-Martin Bruch

Works (26)

Multiplexed Immunophenotyping of Lymphoma Tissue Samples

Methods in Molecular Biology
2025 | Book chapter
Part of ISBN: 9781071641873
Part of ISBN: 9781071641880
Part of ISSN: 1064-3745
Part of ISSN: 1940-6029
Contributors: Christina Schniederjohann; Peter-Martin Bruch; Sascha Dietrich; Frank Neumann
Source: Self-asserted source
Peter-Martin Bruch

CD20-bispecific antibodies improve response to CD19-CAR T cells in lymphoma in vitro and CLL in vivo models

Blood
2024 | Journal article
EID:

2-s2.0-85196840703

Part of ISSN: 15280020 00064971
Contributors: Brinkmann, B.J.; Floerchinger, A.; Schniederjohann, C.; Roider, T.; Coelho, M.; Mack, N.; Bruch, P.-M.; Liebers, N.; Dötsch, S.; Busch, D.H. et al.
Source: Self-asserted source
Peter-Martin Bruch via Scopus - Elsevier
grade
Preferred source (of 2)‎

Characterization of Vascular Niche in Systemic Sclerosis by Spatial Proteomics

Circulation Research
2024 | Journal article
EID:

2-s2.0-85189376392

Part of ISSN: 15244571 00097330
Contributors: Rigau, A.R.; Li, Y.-N.; Matei, A.-E.; Györfi, A.-H.; Bruch, P.-M.; Koziel, S.; Devakumar, V.; Gabrielli, A.; Kreuter, A.; Wang, J. et al.
Source: Self-asserted source
Peter-Martin Bruch via Scopus - Elsevier
grade
Preferred source (of 2)‎

Integrative multi-omics identifies regulatory and exhausted T cell types and novel immunotherapy targets in CLL lymph nodes

Research Square
2024 | Other
EID:

2-s2.0-85189954483

Contributors: Seiffert, M.; Cid, L.L.; Wong, J.; Floerchinger, A.; Paul, Y.; Schifflers, C.; Mallm, J.-P.; Lichter, P.; Iskar, M.; Zapatka, M. et al.
Source: Self-asserted source
Peter-Martin Bruch via Scopus - Elsevier

Multimodal and spatially resolved profiling identifies distinct patterns of T cell infiltration in nodal B cell lymphoma entities

Nature Cell Biology
2024 | Journal article
EID:

2-s2.0-85185910527

Part of ISSN: 14764679 14657392
Contributors: Roider, T.; Baertsch, M.A.; Fitzgerald, D.; Vöhringer, H.; Brinkmann, B.J.; Czernilofsky, F.; Knoll, M.; Llaó-Cid, L.; Mathioudaki, A.; Faßbender, B. et al.
Source: Self-asserted source
Peter-Martin Bruch via Scopus - Elsevier

Novel meriolin derivatives potently inhibit cell cycle progression and transcription in leukemia and lymphoma cells via inhibition of cyclin-dependent kinases (CDKs)

Cell Death Discovery
2024 | Journal article
EID:

2-s2.0-85195943335

Part of ISSN: 20587716
Contributors: Schmitt, L.; Hoppe, J.; Cea-Medina, P.; Bruch, P.-M.; Krings, K.S.; Lechtenberg, I.; Drießen, D.; Peter, C.; Bhatia, S.; Dietrich, S. et al.
Source: Self-asserted source
Peter-Martin Bruch via Scopus - Elsevier
grade
Preferred source (of 3)‎

T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia

Blood
2024 | Journal article
EID:

2-s2.0-85197904034

Part of ISSN: 15280020 00064971
Contributors: Roessner, P.M.; Seufert, I.; Chapaprieta, V.; Jayabalan, R.; Briesch, H.; Massoni-Badosa, R.; Boskovic, P.; Benckendorff, J.; Roider, T.; Arseni, L. et al.
Source: Self-asserted source
Peter-Martin Bruch via Scopus - Elsevier

Aggressive Lymphoma after CD19 CAR T-Cell Therapy

New England Journal of Medicine
2024-10-03 | Journal article
Part of ISSN: 0028-4793
Part of ISSN: 1533-4406
Contributors: Guido Kobbe; Monika Brüggemann; Ben-Niklas Baermann; Laura Wiegand; Heiko Trautmann; Schayan Yousefian; Silvana Libertini; Hans D. Menssen; Harald J. Maier; Peter Ulrich et al.
Source: Self-asserted source
Peter-Martin Bruch

A single-cell multi-omic and spatial atlas of B cell lymphomas reveals differentiation drives intratumor heterogeneity

bioRxiv
2023 | Other
EID:

2-s2.0-85180594664

Part of ISSN: 26928205
Contributors: Fitzgerald, D.; Roider, T.; Baertsch, M.-A.; Kibler, A.; Horlova, A.; Chung, E.; Vöhringer, H.; Mathioudaki, A.; Budeus, B.; Passerini, V. et al.
Source: Self-asserted source
Peter-Martin Bruch via Scopus - Elsevier

Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrial

Nature Cancer
2023 | Journal article
EID:

2-s2.0-85173089254

Part of ISSN: 26621347
Contributors: Liebers, N.; Bruch, P.-M.; Terzer, T.; Hernandez-Hernandez, M.; Paramasivam, N.; Fitzgerald, D.; Altmann, H.; Roider, T.; Kolb, C.; Knoll, M. et al.
Source: Self-asserted source
Peter-Martin Bruch via Scopus - Elsevier
grade
Preferred source (of 2)‎

Functional analysis of structural variants in single cells using Strand-seq

Nature Biotechnology
2023 | Journal article
EID:

2-s2.0-85142526943

Part of ISSN: 15461696 10870156
Contributors: Jeong, H.; Grimes, K.; Rauwolf, K.K.; Bruch, P.-M.; Rausch, T.; Hasenfeld, P.; Benito, E.; Roider, T.; Sabarinathan, R.; Porubsky, D. et al.
Source: Self-asserted source
Peter-Martin Bruch via Scopus - Elsevier
grade
Preferred source (of 2)‎

Comparing the value of mono- versus coculture for high-throughput compound screening in hematological malignancies

Blood Advances
2023-06-23 | Journal article
EID:

2-s2.0-85151777347

Part of ISSN: 26928205
Part of ISSN: 2473-9529
Part of ISSN: 2473-9537
EID:

2-s2.0-85173894166

Contributors: Sophie A Herbst; Vladislav Kim; Tobias Roider; Eva C. Schitter; Peter-Martin Bruch; Nora Liebers; Carolin Kolb; Mareike Knoll; Junyan Lu; Peter Dreger et al.
Source: Self-asserted source
Peter-Martin Bruch
grade
Preferred source (of 5)‎

Drug-microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL

Molecular Systems Biology
2022 | Journal article
EID:

2-s2.0-85136343006

Part of ISSN: 17444292
Contributors: Bruch, P.-M.; Giles, H.A.R.; Kolb, C.; Herbst, S.A.; Becirovic, T.; Roider, T.; Lu, J.; Scheinost, S.; Wagner, L.; Huellein, J. et al.
Source: Self-asserted source
Peter-Martin Bruch via Scopus - Elsevier
grade
Preferred source (of 2)‎

High-dimensional single-cell definition of CLL T cells identifies Galectin-9 as novel immunotherapy target

bioRxiv
2022 | Other
EID:

2-s2.0-85173875572

Part of ISSN: 26928205
Contributors: Cid, L.L.; Wong, J.K.L.; Botana, F.; Paul, Y.; Wierz, M.; Flörchinger, A.; Gonder, S.; Pagano, G.; Chazotte, M.; Bestak, K. et al.
Source: Self-asserted source
Peter-Martin Bruch via Scopus - Elsevier

Humoral and cellular responses after COVID-19 vaccination in anti-CD20-treated lymphoma patients

Blood
2022 | Journal article
EID:

2-s2.0-85122267259

Part of ISSN: 15280020 00064971
Contributors: Liebers, N.; Speer, C.; Benning, L.; Bruch, P.-M.; Kraemer, I.; Meissner, J.; Schnitzler, P.; Kräusslich, H.-G.; Dreger, P.; Mueller-Tidow, C. et al.
Source: Self-asserted source
Peter-Martin Bruch via Scopus - Elsevier
grade
Preferred source (of 2)‎

Longitudinal analyses of CLL in mice identify leukemia-related clonal changes including a Myc gain predicting poor outcome in patients

Leukemia
2022 | Journal article
EID:

2-s2.0-85113267622

Part of ISSN: 14765551 08876924
Contributors: Öztürk, S.; Paul, Y.; Afzal, S.; Gil-Farina, I.; Jauch, A.; Bruch, P.-M.; Kalter, V.; Hanna, B.; Arseni, L.; Roessner, P.M. et al.
Source: Self-asserted source
Peter-Martin Bruch via Scopus - Elsevier
grade
Preferred source (of 2)‎

Multimodal and spatially resolved profiling identifies distinct patterns of T-cell infiltration in nodal B-cell lymphoma entities

bioRxiv
2022 | Other
EID:

2-s2.0-85146955662

Part of ISSN: 26928205
Contributors: Roider, T.; Baertsch, M.A.; Fitzgerald, D.; Voehringer, H.; Brinkmann, B.J.; Czernilofsky, F.; Knoll, M.; Llaó-Cid, L.; Bruch, P.-M.; Liebers, N. et al.
Source: Self-asserted source
Peter-Martin Bruch via Scopus - Elsevier
grade
Preferred source (of 2)‎

Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1

Blood
2022 | Journal article
EID:

2-s2.0-85142901023

Part of ISSN: 15280020 00064971
Contributors: Janssen, M.; Schmidt, C.; Bruch, P.-M.; Blank, M.F.; Rohde, C.; Waclawiczek, A.; Heid, D.; Renders, S.; Göllner, S.; Vierbaum, L. et al.
Source: Self-asserted source
Peter-Martin Bruch via Scopus - Elsevier
grade
Preferred source (of 2)‎

Retrospective analysis of hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: conditioning intensity matters

Leukemia
2022-12-22 | Journal article
Part of ISSN: 0887-6924
Part of ISSN: 1476-5551
Contributors: Peter-Martin Bruch; Sascha Dietrich; Herve Finel; Ariane Boumendil; Hildegard Greinix; Thomas Heinicke; Wolfgang Bethge; Dietrich Beelen; Christoph Schmid; Hans Martin et al.
Source: Self-asserted source
Peter-Martin Bruch
grade
Preferred source (of 2)‎

Proteogenomics refines the molecular classification of chronic lymphocytic leukemia

Nature Communications
2022-10-20 | Journal article | Author
EID:

2-s2.0-85129184761

Part of ISSN: 26928205
Part of ISSN: 2041-1723
EID:

2-s2.0-85140255085

Contributors: Sophie A Herbst; Mattias Vesterlund; Alexander J. Helmboldt; Rozbeh Jafari; Ioannis Siavelis; Matthias Stahl; Eva C. Schitter; Nora Liebers; Berit Brinkmann; Felix Czernilofsky et al.
Source: Self-asserted source
Peter-Martin Bruch
grade
Preferred source (of 3)‎

Combinatorial drug-microenvironment interaction mapping reveals cell-extrinsic drug resistance mechanisms and clinically relevant patient subgroups in CLL

bioRxiv
2021 | Other
EID:

2-s2.0-85121943003

Part of ISSN: 26928205
Contributors: Bruch, P.-M.; Giles, H.A.R.; Kolb, C.; Herbst, S.A.; Becirovic, T.; Roider, T.; Lu, J.; Scheinost, S.; Wagner, L.; Huellein, J. et al.
Source: Self-asserted source
Peter-Martin Bruch via Scopus - Elsevier
grade
Preferred source (of 2)‎

Haplotype-aware single-cell multiomics uncovers functional effects of somatic structural variation

bioRxiv
2021 | Other
EID:

2-s2.0-85121561316

Part of ISSN: 26928205
Contributors: Jeong, H.; Grimes, K.; Bruch, P.-M.; Rausch, T.; Hasenfeld, P.; Sabarinathan, R.; Porubsky, D.; Herbst, S.A.; Erarslan-Uysal, B.; Jann, J.-C. et al.
Source: Self-asserted source
Peter-Martin Bruch via Scopus - Elsevier

Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia

Nature Cancer
2021 | Journal article
EID:

2-s2.0-85109344882

Part of ISSN: 26621347
Contributors: Lu, J.; Cannizzaro, E.; Meier-Abt, F.; Scheinost, S.; Bruch, P.-M.; Giles, H.A.R.; Lütge, A.; Hüllein, J.; Wagner, L.; Giacopelli, B. et al.
Source: Self-asserted source
Peter-Martin Bruch via Scopus - Elsevier
grade
Preferred source (of 2)‎

Dissecting intratumour heterogeneity of nodal B-cell lymphomas at the transcriptional, genetic and drug-response levels

Nature Cell Biology
2020 | Journal article
EID:

2-s2.0-85087434183

Part of ISSN: 14764679 14657392
Contributors: Roider, T.; Seufert, J.; Uvarovskii, A.; Frauhammer, F.; Bordas, M.; Abedpour, N.; Stolarczyk, M.; Mallm, J.-P.; Herbst, S.A.; Bruch, P.-M. et al.
Source: Self-asserted source
Peter-Martin Bruch via Scopus - Elsevier
grade
Preferred source (of 2)‎

Dissecting intratumor heterogeneity of nodal B cell lymphomas on the transcriptional, genetic, and drug response level

bioRxiv
2019 | Other
EID:

2-s2.0-85095625149

Part of ISSN: 26928205
Contributors: Roider, T.; Seufert, J.; Uvarovskii, A.; Frauhammer, F.; Bordas, M.; Abedpour, N.; Stolarczyk, M.; Mallm, J.-P.; Rabe, S.; Bruch, P.-M. et al.
Source: Self-asserted source
Peter-Martin Bruch via Scopus - Elsevier

Quantification of Differential Transcription Factor Activity and Multiomics-Based Classification into Activators and Repressors: diffTF

Cell Reports
2019-12 | Journal article
Part of ISSN: 2211-1247
Source: Self-asserted source
Peter-Martin Bruch
grade
Preferred source (of 2)‎